The future of regulatory affairs

The future of regulatory affairs

Industry perspectives and a strategic roadmap for AI transformation in life sciences

As regulatory affairs transitions from being a document-driven, compliance focussed function into a data-enabled, insight-led capability, organisations are questioning how best to manage this structural change.

While many organisations have already began adopting AI, current use remains largely fragmented and focussed on productivity gains. But by simply concentrating on efficiency, organisations are ignoring the real opportunity. Instead, they should redesign how their regulatory data is structured, governed, and leveraged to support faster, more informed decision-making across the entire product lifecycle.

The key question is how can organisations improve their AI integration to remain competitive?

The solution, according to our experts, is by using two key frameworks:

  • A three-horizon model outlining the transition from AI-assisted to AI-embedded and ultimately AI-native regulatory operating models. 

  • A five-stage AI maturity model enabling organisations to assess readiness and define a path to scaled, responsible AI adoption.

Download and read our whitepaper to learn more about these frameworks, including how AI can improve your efficiency while reducing your regulatory friction, strengthening your compliance, and aligning with your broader enterprise strategy.

The future of regulatory affairs

When it comes to AI and regulatory affairs, it’s time to go beyond efficiency for faster and more informed decision making. Download our whitepaper on the future of regulatory affairs to discover more.

Contact us

Matthias Reyntjens
Matthias Reyntjens

Partner, Clients and Industries, PwC Belgium

Jan Debaere
Jan Debaere

Partner, Health Industries Lead, PwC Belgium

Richard Boxall
Richard Boxall

External Senior Advisor, Life Sciences and Healthcare, PwC Belgium

Connect with PwC Belgium